Utilisation and safety of asenapine in secondary care in the United Kingdom: Results from the observational safety evaluation of asenapine (OBSERVA) study

被引：0
|
作者：
Dhanda, Sandeep [1 ,2 ]
Slade, Jan [1 ]
Osborne, Vicki [1 ]
Wise, Lesley [1 ]
Shakir, Saad [1 ,2 ]
机构：
[1] Drug Safety Res Unit, Southampton, Hants, England
[2] Univ Portsmouth, Portsmouth, Hants, England
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2018年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
593
引用
收藏
页码：272 / 273
页数：2
相关论文
共 50 条
  • [1] Utilisation and Safety of Asenapine in Secondary Care in the UK: Results from the Observational Safety Evaluation of Asenapine (OBSERVA) Study
    Dhanda, S.
    Slade, J.
    Obsorne, V.
    Wise, L.
    Shakir, S.
    DRUG SAFETY, 2018, 41 (11) : 1129 - 1130
  • [2] The Observational Safety Evaluation of Asenapine (OBSERVA) Study: Rationale and Design
    Layton, Deborah
    Mitchell, Felicity
    Shakir, Saad A. W.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 106 - 106
  • [3] The Observational Safety Evaluation of Asenapine (OBSERVA) Study: Rationale and Design
    Layton, D.
    Mitchell, F.
    Shakir, S. A.
    DRUG SAFETY, 2013, 36 (09) : 857 - 858
  • [4] Utilisation and safety of asenapine in primary care in England: Results from a PASS
    Dhanda, Sandeep
    Coukan, Flavien
    Wise, Lesley
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 272 - 272
  • [5] Utilisation and Safety of Asenapine in Primary Care in England: Results Rom a PASS
    Dhanda, S.
    Coukan, F.
    Wise, L.
    Shakir, S.
    DRUG SAFETY, 2018, 41 (11) : 1129 - 1129
  • [6] Asenapine in clinical practice: preliminary results from a naturalistic observational study
    Gramaglia, Carla
    Rizza, Maria Cristina
    Gattoni, Eleonora
    Gambaro, Eleonora
    Di Marco, Sarah
    Coppola, Isabella
    Rossi, Annalisa
    Jona, Amalia
    Imperatori, Fredrica
    Prosperini, Pierluigi
    Chieppa, Nunzia
    Binda, Valeria
    Farruggio, Serena
    Grossini, Elena
    Zeppegno, Patrizia
    RIVISTA DI PSICHIATRIA, 2014, 49 (06) : 241 - 246
  • [7] Utilisation and safety of rivaroxaban for acute coronary syndrome (ACS) in secondary care in the UK: Results from the rivaroxaban observational safety evaluation post ACS (ROSE-ACS) study
    Evans, Alison
    Dhanda, Sandeep
    Osborne, Vicki
    Roy, Debabrata
    Shakir, Saad
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 469 - 469
  • [8] Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England
    Vicki Osborne
    Miranda Davies
    Deborah Layton
    Saad A. W. Shakir
    Drug Safety, 2018, 41 : 267 - 275
  • [9] Utilisation and Safety of Deferasirox: Results from an Observational Cohort Study in England
    Osborne, Vicki
    Davies, Miranda
    Layton, Deborah
    Shakir, Saad A. W.
    DRUG SAFETY, 2018, 41 (03) : 267 - 275
  • [10] Utilisation and Safety of Deferasirox (Exjade®): Results from an Observational Cohort Study in England
    Osborne, V.
    Davies, M.
    Layton, D.
    Shakir, S.
    DRUG SAFETY, 2015, 38 (10) : 1026 - 1027
12345